Table 2.
CD4 and RNA at initiation and at 8 month (or last visit) by levels of ART adherence (N = 60)
| Attended all clinic visits (n = 40) | Attended some clinic visits, including 8 month visit (n = 13) | Stopped ART before 8 month visit (n = 7) | Total (n = 60) | |
|---|---|---|---|---|
| CD4 Count |
|
|
|
|
| Initiation CD4 Count: n(%) |
38 (95%) |
13 (100%) |
5 (71%) |
56 (93%) |
| Median (IQR) |
219 (145,306) |
213 (84,323) |
160 (124,216) |
215 (129,301) |
| Follow-up CD4 Count: n(%) |
38 (95%) |
13 (100%) |
5 (71%) |
56 (93%) |
| Median (IQR) |
316 (194,384) |
308 (113,360) |
123 (100,253) |
293 (154,382) |
| |
p = 0.02 |
p = 0.03 |
p = 0.5 |
|
| Viral Load (VL) |
|
|
|
|
| Initiation VL: n(%) |
35 (88%) |
12 (92%) |
4 (57%) |
51 (85%) |
| RNA <1000: n(%) |
16 (46%) |
4 (33%) |
1 (25%) |
21 (41%) |
| Median (IQR) |
5840 (61,156000) |
7440 (114,872779) |
341259 (75232,911102) |
12000 (75,268000) |
| Final VL: n(%) |
37 (93%) |
12 (92%) |
4 (57 %) |
53 (88%) |
| RNA <1000: n(%) |
31 (84%)* |
7 (58%)* |
1 (25%)* |
39 (74%) |
| |
p < 0.001 |
p = 0.4 |
p = 1.0 |
|
| Median (IQR) | 50 (50,400)** | 275 (50,7022)** | 3750 (907,153000)** | 64 (50,1030) |
*p = 0.02 **p = 0.04.